The Economist provides independent journalism for independent thinking and has been

championing progress for almost 200 years.

With the Economist, you gain access to fact-based, deeply researched expert analysis of world events and topics

ranging from business and culture to politics, science and technology.

Tune into the global conversation with reporting from correspondence around the world,

available in-app online through podcasts and print.

So for fact sake, search the economist. All right. I'm been looking forward to this conversation for a while. This is a conversation with a guy who I first heard of when he was rumored

to be in the running for head of the FDA under Trump in his first term which

caught my attention because I was in biotech back then.

And the more I got to know about him, the more I realized that we had some similarities

in our, not only our backgrounds, about our paths and some of our interests, even if we have different views at times.

Biology Sri Vosin, welcome to the podcast man.

Good to be here, Vic.

So I think this will be the longest, certainly the longest conversation we've had.

We've only started really speaking

even over the course of the last year or year and a half but I've known about

you indirectly through folks in Silicon Valley all of whom point to you as some type of

or Oracle figure which got me intrigued by you but

tell me what got you you know potentially at least whether you were considering it or not I don't know

although I'd be interested were you actually

considering being head of the FDA but what got you to the point of even being in the

running to be head of the FDA and more generally maybe a little bit of background

...